BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 33785065)

  • 21. Distinct prion-like strains of amyloid beta implicated in phenotypic diversity of Alzheimer's disease.
    Cohen M; Appleby B; Safar JG
    Prion; 2016; 10(1):9-17. PubMed ID: 26809345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence for human transmission of amyloid-β pathology and cerebral amyloid angiopathy.
    Jaunmuktane Z; Mead S; Ellis M; Wadsworth JD; Nicoll AJ; Kenny J; Launchbury F; Linehan J; Richard-Loendt A; Walker AS; Rudge P; Collinge J; Brandner S
    Nature; 2015 Sep; 525(7568):247-50. PubMed ID: 26354483
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distinct deposition of amyloid-β species in brains with Alzheimer's disease pathology visualized with MALDI imaging mass spectrometry.
    Kakuda N; Miyasaka T; Iwasaki N; Nirasawa T; Wada-Kakuda S; Takahashi-Fujigasaki J; Murayama S; Ihara Y; Ikegawa M
    Acta Neuropathol Commun; 2017 Oct; 5(1):73. PubMed ID: 29037261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The characterization of AD/PART co-pathology in CJD suggests independent pathogenic mechanisms and no cross-seeding between misfolded Aβ and prion proteins.
    Rossi M; Kai H; Baiardi S; Bartoletti-Stella A; Carlà B; Zenesini C; Capellari S; Kitamoto T; Parchi P
    Acta Neuropathol Commun; 2019 Apr; 7(1):53. PubMed ID: 30961668
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prion protein is decreased in Alzheimer's brain and inversely correlates with BACE1 activity, amyloid-β levels and Braak stage.
    Whitehouse IJ; Miners JS; Glennon EB; Kehoe PG; Love S; Kellett KA; Hooper NM
    PLoS One; 2013; 8(4):e59554. PubMed ID: 23577068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
    Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
    Elife; 2020 Jun; 9():. PubMed ID: 32510331
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aβ and Tau Prions Causing Alzheimer's Disease.
    Condello C; Merz GE; Aoyagi A; DeGrado WF; Prusiner SB
    Methods Mol Biol; 2023; 2561():293-337. PubMed ID: 36399277
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Abundance of Aβ₅-x like immunoreactivity in transgenic 5XFAD, APP/PS1KI and 3xTG mice, sporadic and familial Alzheimer's disease.
    Guzmán EA; Bouter Y; Richard BC; Lannfelt L; Ingelsson M; Paetau A; Verkkoniemi-Ahola A; Wirths O; Bayer TA
    Mol Neurodegener; 2014 Apr; 9():13. PubMed ID: 24694184
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Titration of biologically active amyloid-β seeds in a transgenic mouse model of Alzheimer's disease.
    Morales R; Bravo-Alegria J; Duran-Aniotz C; Soto C
    Sci Rep; 2015 Mar; 5():9349. PubMed ID: 25879692
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of amyloid-β deposits from serially transmitted, histologically silent, Aβ seeds issued from human brains.
    Hérard AS; Petit F; Gary C; Guillermier M; Boluda S; Garin CM; ; Lam S; Dhenain M
    Acta Neuropathol Commun; 2020 Nov; 8(1):205. PubMed ID: 33250056
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PDK1 decreases TACE-mediated α-secretase activity and promotes disease progression in prion and Alzheimer's diseases.
    Pietri M; Dakowski C; Hannaoui S; Alleaume-Butaux A; Hernandez-Rapp J; Ragagnin A; Mouillet-Richard S; Haik S; Bailly Y; Peyrin JM; Launay JM; Kellermann O; Schneider B
    Nat Med; 2013 Sep; 19(9):1124-31. PubMed ID: 23955714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heparanase overexpression impedes perivascular clearance of amyloid-β from murine brain: relevance to Alzheimer's disease.
    Zhang X; O'Callaghan P; Li H; Tan Y; Zhang G; Barash U; Wang X; Lannfelt L; Vlodavsky I; Lindahl U; Li JP
    Acta Neuropathol Commun; 2021 May; 9(1):84. PubMed ID: 33971986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phosphorylated Aβ peptides in human Down syndrome brain and different Alzheimer's-like mouse models.
    Kumar S; Lemere CA; Walter J
    Acta Neuropathol Commun; 2020 Jul; 8(1):118. PubMed ID: 32727580
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Altering Brain Amyloidosis by Intra-Lingual and Extra-Nasal Exposure of Aβ Aggregates.
    Gamez N; Bravo-Alegria J; Huang Y; Perez-Urrutia N; Dongarwar D; Soto C; Morales R
    Cells; 2022 Oct; 11(21):. PubMed ID: 36359840
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of monomeric and soluble aggregated Aβ in Down's syndrome and Alzheimer's disease brains.
    Gkanatsiou E; Sahlin C; Portelius E; Johannesson M; Söderberg L; Fälting J; Basun H; Möller C; Odergren T; Zetterberg H; Blennow K; Lannfelt L; Brinkmalm G
    Neurosci Lett; 2021 May; 754():135894. PubMed ID: 33848613
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular subtypes of Alzheimer's disease.
    Di Fede G; Catania M; Maderna E; Ghidoni R; Benussi L; Tonoli E; Giaccone G; Moda F; Paterlini A; Campagnani I; Sorrentino S; Colombo L; Kubis A; Bistaffa E; Ghetti B; Tagliavini F
    Sci Rep; 2018 Feb; 8(1):3269. PubMed ID: 29459625
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Abeta as a bioflocculant: implications for the amyloid hypothesis of Alzheimer's disease.
    Robinson SR; Bishop GM
    Neurobiol Aging; 2002; 23(6):1051-72. PubMed ID: 12470802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blast-Mediated Traumatic Brain Injury Exacerbates Retinal Damage and Amyloidosis in the APPswePSENd19e Mouse Model of Alzheimer's Disease.
    Harper MM; Hedberg-Buenz A; Herlein J; Abrahamson EE; Anderson MG; Kuehn MH; Kardon RH; Poolman P; Ikonomovic MD
    Invest Ophthalmol Vis Sci; 2019 Jun; 60(7):2716-2725. PubMed ID: 31247112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interactions between amyloid-β and hemoglobin: implications for amyloid plaque formation in Alzheimer's disease.
    Chuang JY; Lee CW; Shih YH; Yang T; Yu L; Kuo YM
    PLoS One; 2012; 7(3):e33120. PubMed ID: 22412990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Physiological amyloid-beta clearance in the periphery and its therapeutic potential for Alzheimer's disease.
    Xiang Y; Bu XL; Liu YH; Zhu C; Shen LL; Jiao SS; Zhu XY; Giunta B; Tan J; Song WH; Zhou HD; Zhou XF; Wang YJ
    Acta Neuropathol; 2015 Oct; 130(4):487-99. PubMed ID: 26363791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.